Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Video summary

Longevity discussion: 12 hallmarks, Novos Core trials, biological age clocks

In this video description, Chris Mirabile links his brain tumor at 16 to his focus on prevention and describes the 12 hallmarks of aging framework behind the supplement Novos Core, plus reported trial results, biological age tests and his personal routine. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says a seizure at 16 led to the discovery of a brain tumor and to Mirabile's focus on prevention. [1]

  2. The description reports randomized human trials of Novos Core showing effects on oxidative DNA damage, cellular senescence and cardiovascular biomarkers. [1]

  3. The description lists DunedinPACE and GrimAge clocks, mTOR and AMPK cycling, and Mirabile's personal routine including strength training and sleep. [1]

The source at a glance

Study type / format
Video description of a podcast episode
Population / context
Viewers of a longevity podcast episode; the guest is Chris Mirabile, founder and CEO of Novos Labs.
Summary based on
Creator description
Original publication
February 24, 2026

Mirabile's tumor and prevention focus

According to the description, host Nicole Doran speaks with Chris Mirabile, founder and CEO of Novos Labs and author of Slow My Age. It says a seizure at 16 led to the discovery of a brain tumor, after which he focused on disease prevention and on aging as the primary driver of chronic illness. The description presents this as his personal background, not as evidence about causes of illness.

Supporting source [1]

Hallmarks framework and reported Novos Core trials

The description says Mirabile explains the 12 hallmarks of aging framework that informs Novos Core, a supplement designed to target multiple aging pathways at once. It mentions randomized human trials reporting reductions in oxidative DNA damage, effects on cellular senescence and improvements in cardiovascular biomarkers. These are described results, not established benefits for lifespan or disease; the description gives no trial sizes, durations or effect sizes.

Supporting source [1]

Biological age clocks, protein debate and personal routine

The description lists discussion of biological age testing with DunedinPACE and GrimAge clocks, longevity marketing and extreme lifespan claims, the protein paradox with mTOR and AMPK cycling, and sex differences in lifespan and hormone signaling. Mirabile also shares a personal protocol: strength training, time-restricted eating, seafood-focused nutrition, high-polyphenol olive oil, targeted supplementation and sleep as a foundational pillar. The description calls sleep underrated but reports no measured sleep outcome.

Supporting source [1]

How to interpret this

Only the video description was reviewed; the video and transcript were not reviewed. All claims are attributed to the description and creator. No trial sizes, durations, effect sizes or full results are given, and the description does not establish lifespan or disease benefits.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Can You Slow Aging? The Science Behind Longevity with Chris Mirabile

The Healthspan Collective · youtube.com · February 24, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    a seizure at 16 that led to
  2. Finding 2 ↑

    improvements in cardiovascular biomarkers from randomized human
  3. Finding 3 ↑

    including DunedinPACE and GrimAge clocks

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…